F. Ciencias de la Salud
Facultades


Hospital Universitario de Donostia
San Sebastián, EspañaPublications in collaboration with researchers from Hospital Universitario de Donostia (23)
2022
-
Parkinson's Disease Motor Subtypes Change with the Progression of the Disease: Results from the COPPADIS Cohort at 2-Year Follow-Up
Journal of Parkinson's Disease, Vol. 12, Núm. 3, pp. 935-955
-
Constipation Predicts Cognitive Decline in Parkinson's Disease: Results from the COPPADIS Cohort at 2-Year Follow-up and Comparison with a Control Group
Journal of Parkinson's Disease, Vol. 12, Núm. 1, pp. 315-331
2021
-
Staging Parkinson’s disease combining motor and nonmotor symptoms correlates with disability and quality of life
Parkinson's Disease, Vol. 2021
-
Sleep Problems Are Related to a Worse Quality of Life and a Greater Non-Motor Symptoms Burden in Parkinson’s Disease
Journal of Geriatric Psychiatry and Neurology, Vol. 34, Núm. 6, pp. 642-658
-
Predictors of loss of functional independence in parkinson’s disease: Results from the coppadis cohort at 2-year follow-up and comparison with a control group
Diagnostics, Vol. 11, Núm. 10
-
Predictors of global non-motor symptoms burden progression in parkinson’s disease. Results from the coppadis cohort at 2-year follow-up
Journal of Personalized Medicine, Vol. 11, Núm. 7
-
Predictors of clinically significant quality of life impairment in Parkinson’s disease
npj Parkinson's Disease, Vol. 7, Núm. 1
-
Mood in Parkinson's disease: From early- to late-stage disease
International journal of geriatric psychiatry, Vol. 36, Núm. 5, pp. 627-646
-
Identifying comorbidities and lifestyle factors contributing to the cognitive profile of early Parkinson’s disease
BMC Neurology, Vol. 21, Núm. 1
-
Epidemiology of ataxia and hereditary spastic paraplegia in Spain: a cross-sectional study
Neurologia
-
Diplopia is frequent and associated with motor and non-motor severity in parkinson’s disease: Results from the COPPADIS cohort at 2-year follow-up
Diagnostics, Vol. 11, Núm. 12
2020
-
Correction to: A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity (Acta Neuropathologica, (2019), 138, 2, (237-250), 10.1007/s00401-019-02026-8)
Acta Neuropathologica
-
Quality of life and non-motor symptoms in Parkinson's disease patients with subthreshold depression
Journal of the Neurological Sciences, Vol. 418
-
Non-motor symptom burden in patients with Parkinson’s disease with impulse control disorders and compulsive behaviours: results from the COPPADIS cohort
Scientific Reports, Vol. 10, Núm. 1
-
Clinical utility of a personalized and long-term monitoring device for Parkinson's disease in a real clinical practice setting: An expert opinion survey on STAT-ON™
Neurologia
2019
-
COPPADIS-2015 (COhort of Patients with PArkinson's DIsease in Spain, 2015): an ongoing global Parkinson's disease project about disease progression with more than 1000 subjects included. Results from the baseline evaluation
European Journal of Neurology, Vol. 26, Núm. 11, pp. 1399-1407
2018
-
Pooled-DNA target sequencing of Parkinson genes reveals novel phenotypic associations in Spanish population
Neurobiology of Aging, Vol. 70, pp. 325.e1-325.e5
2016
-
Erratum to: COPPADIS-2015 (COhort of Patients with PArkinson's DIsease in Spain, 2015), a global -clinical evaluations, serum biomarkers, genetic studies and neuroimaging- prospective, multicenter, non-interventional, long-term study on Parkinson's disease progression [BMC Neurol. 16, (2015), 26] DOI: 10.1186/s12883-016-0548-9
BMC Neurology
-
COPPADIS-2015 (COhort of Patients with PArkinson's DIsease in Spain, 2015), a global -clinical evaluations, serum biomarkers, genetic studies and neuroimaging- prospective, multicenter, non-interventional, long-term study on Parkinson's disease progression
BMC Neurology, Vol. 16, Núm. 1